Retour aux promos
myFibroScan

Medecine

Gratuit

myFibroScan

par ECHOSENS

v2.5.0 40 Mo Universel 17+

Description

FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health.

FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines.

myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :

The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results.

Scores enhance FibroScan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.

• Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast.
• Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
• Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.

Nouveautés (v2.5.0)

myFibroScan, your Everyday FibroScan® Companion, evolves to bring you:
• Updated Clinical References: The Interpretation Guide now includes the most recent publications, ensuring the tool reflects the latest clinical knowledge.
• Translated in Italian in addition to the existing English, French and German version